Skip to main content
. Author manuscript; available in PMC: 2014 Oct 9.
Published in final edited form as: J Thorac Oncol. 2013 Aug;8(8):1084–1090. doi: 10.1097/JTO.0b013e31829923ec

Table 2. Chemotherapy Delivery.

Drug Cycles N Dose-limiting Event (N)

Bevacizumab
3 40 Diverticulitis with perforation(1)
2 2 Hemoptysis(1), hypertension(1)
1 8 Hemoptysis(3), Cavitary PNA(1), docetaxel reaction (2), sepsis/death(1), sepsis/pneumonitis(1)
Docetaxel/Cisplatin
4 42
3 3 Transaminitis(1), fatigue(1)
2 0
1 5 Cavitary PNA(1), docetaxel reaction(2), sepsis/death(1), sepsis/pneumonitis(1)
Adjuvant bevacizumab
18 9
17 2 Patient preference(2)
14 1 Hemoptysis
13 2 Fatigue(1), withdrew consent(1)
10 1 EKG changes
4-7 3 Progression of Disease(3)
1 1 Hypertensive urgency